IHC (immunohistochemistry) revealed a Brachyury, PDGFR-β and EGFR 2+ positive tumor (R pharmDxTM Dako kit) with evidence of pS6 phosphorylation in more than 70% of cells. Here, EGFR is linked to neoplasm.